173 related articles for article (PubMed ID: 23748177)
1. Risk factors for ovarian cancers with and without microsatellite instability.
Segev Y; Pal T; Rosen B; McLaughlin JR; Sellers TA; Risch HA; Zhang S; Ping S; Narod SA; Schildkraut J
Int J Gynecol Cancer; 2013 Jul; 23(6):1010-5. PubMed ID: 23748177
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for ovarian cancers with and without microsatellite instability.
Segev Y; Pal T; Rosen B; McLaughlin JR; Sellers TA; Risch HA; Zhang S; Sun P; Narod SA; Schildkraut J
Int J Gynecol Cancer; 2014 May; 24(4):664-9. PubMed ID: 24755492
[TBL] [Abstract][Full Text] [Related]
3. The clinical importance of BRCAness in a population-based cohort of Danish epithelial ovarian cancer.
Hjortkjær M; Malik Aagaard Jørgensen M; Waldstrøm M; Ørnskov D; Søgaard-Andersen E; Jakobsen A; Dahl-Steffensen K
Int J Gynecol Cancer; 2019 Jan; 29(1):166-173. PubMed ID: 30640700
[TBL] [Abstract][Full Text] [Related]
4. Anti-Müllerian hormone and risk of ovarian cancer in nine cohorts.
Jung S; Allen N; Arslan AA; Baglietto L; Barricarte A; Brinton LA; Egleston BL; Falk RT; Fortner RT; Helzlsouer KJ; Gao Y; Idahl A; Kaaks R; Krogh V; Merritt MA; Lundin E; Onland-Moret NC; Rinaldi S; Schock H; Shu XO; Sluss PM; Staats PN; Sacerdote C; Travis RC; Tjønneland A; Trichopoulou A; Tworoger SS; Visvanathan K; Weiderpass E; Zeleniuch-Jacquotte A; Dorgan JF
Int J Cancer; 2018 Jan; 142(2):262-270. PubMed ID: 28921520
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory Markers and Risk of Epithelial Ovarian Cancer by Tumor Subtypes: The EPIC Cohort.
Ose J; Schock H; Tjønneland A; Hansen L; Overvad K; Dossus L; Clavel-Chapelon F; Baglietto L; Boeing H; Trichopolou A; Benetou V; Lagiou P; Masala G; Tagliabue G; Tumino R; Sacerdote C; Mattiello A; Bueno-de-Mesquita HB; Peeters PH; Onland-Moret NC; Weiderpass E; Gram IT; Sánchez S; Obon-Santacana M; Sànchez-Pérez MJ; Larrañaga N; Castaño JM; Ardanaz E; Brändstedt J; Lundin E; Idahl A; Travis RC; Khaw KT; Rinaldi S; Romieu I; Merritt MA; Gunter MJ; Riboli E; Kaaks R; Fortner RT
Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):951-61. PubMed ID: 25855626
[TBL] [Abstract][Full Text] [Related]
6. Epithelial Ovarian Cancer with Endometriosis is not Associated with Menopausal Status: a Co-Association Study at Prapokklao Hospital.
Muangtan S; Suknikhom W; Sananpanichkul P; Bhamarapravatana K; Suwannarurk K
Asian Pac J Cancer Prev; 2018 May; 19(5):1337-1341. PubMed ID: 29802696
[TBL] [Abstract][Full Text] [Related]
7. Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium.
Wentzensen N; Poole EM; Trabert B; White E; Arslan AA; Patel AV; Setiawan VW; Visvanathan K; Weiderpass E; Adami HO; Black A; Bernstein L; Brinton LA; Buring J; Butler LM; Chamosa S; Clendenen TV; Dossus L; Fortner R; Gapstur SM; Gaudet MM; Gram IT; Hartge P; Hoffman-Bolton J; Idahl A; Jones M; Kaaks R; Kirsh V; Koh WP; Lacey JV; Lee IM; Lundin E; Merritt MA; Onland-Moret NC; Peters U; Poynter JN; Rinaldi S; Robien K; Rohan T; Sandler DP; Schairer C; Schouten LJ; Sjöholm LK; Sieri S; Swerdlow A; Tjonneland A; Travis R; Trichopoulou A; van den Brandt PA; Wilkens L; Wolk A; Yang HP; Zeleniuch-Jacquotte A; Tworoger SS
J Clin Oncol; 2016 Aug; 34(24):2888-98. PubMed ID: 27325851
[TBL] [Abstract][Full Text] [Related]
8. Association of a newly identified variant of DNA polymerase beta (polβΔ63-123, 208-304) with the risk factor of ovarian carcinoma in India.
Khanra K; Bhattacharya C; Bhattacharyya N
Asian Pac J Cancer Prev; 2012; 13(5):1999-2002. PubMed ID: 22901161
[TBL] [Abstract][Full Text] [Related]
9. Low-dose aspirin use and the risk of ovarian cancer in Denmark.
Baandrup L; Kjaer SK; Olsen JH; Dehlendorff C; Friis S
Ann Oncol; 2015 Apr; 26(4):787-792. PubMed ID: 25538177
[TBL] [Abstract][Full Text] [Related]
10. Agreement for tumor grade of ovarian carcinoma: analysis of archival tissues from the surveillance, epidemiology, and end results residual tissue repository.
Matsuno RK; Sherman ME; Visvanathan K; Goodman MT; Hernandez BY; Lynch CF; Ioffe OB; Horio D; Platz C; Altekruse SF; Pfeiffer RM; Anderson WF
Cancer Causes Control; 2013 Apr; 24(4):749-57. PubMed ID: 23378140
[TBL] [Abstract][Full Text] [Related]
11. Circulating prolactin levels and risk of epithelial ovarian cancer.
Clendenen TV; Arslan AA; Lokshin AE; Liu M; Lundin E; Koenig KL; Berrino F; Hallmans G; Idahl A; Krogh V; Lukanova A; Marrangoni A; Muti P; Nolen BM; Ohlson N; Shore RE; Sieri S; Zeleniuch-Jacquotte A
Cancer Causes Control; 2013 Apr; 24(4):741-8. PubMed ID: 23378139
[TBL] [Abstract][Full Text] [Related]
12. Epidemiologic factors that predict long-term survival following a diagnosis of epithelial ovarian cancer.
Kim SJ; Rosen B; Fan I; Ivanova A; McLaughlin JR; Risch H; Narod SA; Kotsopoulos J
Br J Cancer; 2017 Mar; 116(7):964-971. PubMed ID: 28208158
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for different histological types of ovarian cancer.
Parazzini F; Chiaffarino F; Negri E; Surace M; Benzi G; Franceschi S; Fedele L; La Vecchia C
Int J Gynecol Cancer; 2004; 14(3):431-6. PubMed ID: 15228415
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of p53, Her-2, and EGFR overexpression in borderline and epithelial ovarian cancer.
Nielsen JS; Jakobsen E; Hølund B; Bertelsen K; Jakobsen A
Int J Gynecol Cancer; 2004; 14(6):1086-96. PubMed ID: 15571614
[TBL] [Abstract][Full Text] [Related]
15. Association of reproductive factors, oral contraceptive use and selected lifestyle factors with the risk of ovarian borderline tumors: a Danish case-control study.
Huusom LD; Frederiksen K; Høgdall EV; Glud E; Christensen L; Høgdall CK; Blaakaer J; Kjaer SK
Cancer Causes Control; 2006 Aug; 17(6):821-9. PubMed ID: 16783610
[TBL] [Abstract][Full Text] [Related]
16. Acrylamide and Glycidamide Hemoglobin Adducts and Epithelial Ovarian Cancer: A Nested Case-Control Study in Nonsmoking Postmenopausal Women from the EPIC Cohort.
Obón-Santacana M; Lujan-Barroso L; Travis RC; Freisling H; Ferrari P; Severi G; Baglietto L; Boutron-Ruault MC; Fortner RT; Ose J; Boeing H; Menéndez V; Sánchez-Cantalejo E; Chamosa S; Castaño JM; Ardanaz E; Khaw KT; Wareham N; Merritt MA; Gunter MJ; Trichopoulou A; Papatesta EM; Klinaki E; Saieva C; Tagliabue G; Tumino R; Sacerdote C; Mattiello A; Bueno-de-Mesquita HB; Peeters PH; Onland-Moret NC; Idahl A; Lundin E; Weiderpass E; Vesper HW; Riboli E; Duell EJ
Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):127-34. PubMed ID: 26598536
[TBL] [Abstract][Full Text] [Related]
17. Body mass index and risk of ovarian cancer.
Leitzmann MF; Koebnick C; Danforth KN; Brinton LA; Moore SC; Hollenbeck AR; Schatzkin A; Lacey JV
Cancer; 2009 Feb; 115(4):812-22. PubMed ID: 19127552
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic characteristics and survival in BRCA1- and BRCA2-related adnexal cancer: are they different?
Reitsma W; de Bock GH; Oosterwijk JC; ten Hoor KA; Hollema H; Mourits MJ
Int J Gynecol Cancer; 2012 May; 22(4):579-85. PubMed ID: 22274543
[TBL] [Abstract][Full Text] [Related]
19. A population-based analysis of germline BRCA1 and BRCA2 testing among ovarian cancer patients in an era of histotype-specific approaches to ovarian cancer prevention.
Hanley GE; McAlpine JN; Miller D; Huntsman D; Schrader KA; Blake Gilks C; Mitchell G
BMC Cancer; 2018 Mar; 18(1):254. PubMed ID: 29506471
[TBL] [Abstract][Full Text] [Related]
20. Histologic types of epithelial ovarian cancer: have they different risk factors?
Kurian AW; Balise RR; McGuire V; Whittemore AS
Gynecol Oncol; 2005 Feb; 96(2):520-30. PubMed ID: 15661246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
